Marjorie Ntobongwana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Marjorie Ntobongwana has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Hazel M. Dockrell
Department of Infection Biology and Topical Diseases, London School of Hygiene & Tropical Medicine
1 shared publication - Linda-Gail Bekker
Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa
1 shared publication - Monica Vogt
Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
1 shared publication - Motasim Badri
King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
1 shared publication - Nonzwakazi Bangani
The Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, South Africa
1 shared publication - Robert John Wilkinson
University of Cape Town
1 shared publication
Latest Publications
- Open Access
- 28 August 2007
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 7 (1) , 99
Utility of interferon-γ ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa
Interferon-gamma (IFN-γ) ELISPOT assays incorporating Mycobacterium tuberculosis-specific antigens are useful in the diagnosis of tuberculosis (TB) or latent infection. However, their utility in patients with advanced HIV is unknown. We studied determinants of ELISPOT responses among patients with advanced HIV infection (but without active TB) living in a South African community with very high TB notification rates.
- 28 August 2007
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 7 (1) , 99
Open AccessUtility of interferon-γ ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa
Interferon-gamma (IFN-γ) ELISPOT assays incorporating Mycobacterium tuberculosis-specific antigens are useful in the diagnosis of tuberculosis (TB) or latent infection. However, their utility in patients with advanced HIV is unknown. We studied determinants of ELISPOT responses among patients with advanced HIV infection (but without active TB) living in a South African community with very high TB notification rates.